Founded 2020
Founders Julia Fan Li, CEO, Micrographia Bio Christopher Thompson, CTO, Micrographia Bio

Micrographia Bio is a pioneering applied AI company in the field of spatial proteomics for drug discovery.

Micrographia Bio (MGB) has developed a new approach which uses spatial proteomics for stunningly sensitive and high-throughput assessment of the true molecular effects of drug candidates, which allows for the production of the highest quality drug candidates at a fraction of the time and cost.

This approach rests on a primary innovation – a new type of microscopy that observes hundreds of different types of individual proteins inside cells, simultaneously. Combined with an unrivalled expertise in ML & MLOps for microscopy image analysis, MGB has developed the first high-throughput platform for assessing therapeutic mechanisms of actions via spatial proteomic drug discovery.


Founders

Julia Fan
Li

CEO, Micrographia Bio

Immunologist and recovering VC

Linkedin

Christopher
Thompson

CTO, Micrographia Bio

Molecular biologist, machine learning engineer and roboticist

Linkedin

Related

47 Labs

47 Labs

Lighting up the brain for healthcare.
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
Accelerated Dynamics

Accelerated Dynamics

Technology to drive the 4th industrial revolution.
AccuRx

AccuRx

Powering communications in the healthcare sector.
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.